Sectors
ORIC
ORIC Pharmaceuticals, Inc.
12.79
2 x 9.11
2 x 16.20
bid
ask
-
0.09
0.70%
2 @ 04:18 PM
12.79 +0.00 (0.00%)
| Ytd | 56.36% | |
| 1y | 16.27% |
12.47
day range
12.91
7.47
52 week range
14.65
| Open | 12.81 | Prev Close | 12.88 | Low | 12.47 | High | 12.91 | Mkt Cap | 1.33B |
| Vol | 3.09M | Avg Vol | 1.51M | EPS | -1.30 | P/E | N/A | Forward P/E | -7.79 |
| Beta | 0.99 | Short Ratio | 12.47 | Inst. Own | 122.98% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 12.46 | 200-d Avg | 10.69 | 1yr Est | 20.67 |
| Income Statement | |||
| Operating Expenses | 45.30M | ||
| Research and Development Expense | 36.30M | ||
| Selling, General and Administrative Expense | 9.00M | ||
| Operating Income | -45.30M | ||
| Net Income | -41.49M | ||
| Net Income Common Stock | -41.49M | ||
| Net Income Common Stock (USD) | -41.49M | ||
| Consolidated Income | -41.49M | ||
| Earnings per Basic Share | -0.38 | ||
| Earnings per Basic Share (USD) | -0.38 | ||
| Earnings per Diluted Share | -0.38 | ||
| Earning Before Interest & Taxes (EBIT) | -41.49M | ||
| Earning Before Interest & Taxes (USD) | -41.49M | ||
| Weighted Average Shares | 108.01M | ||
| Weighted Average Shares Diluted | 108.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 37.48M | ||
| Cash and Equivalents (USD) | 37.48M | ||
| Investments | 350.08M | ||
| Investments Current | 227.28M | ||
| Investments Non-Current | 122.80M | ||
| Current Assets | 273.70M | ||
| Property, Plant & Equipment Net | 2.24M | ||
| Total Assets | 404.69M | ||
| Current Liabilities | 20.76M | ||
| Total Liabilities | 23.43M | ||
| Accumulated Retained Earnings (Deficit) | -769.50M | ||
| Accumulated Other Comprehensive Income | -1.02M | ||
| Shareholders Equity | 381.26M | ||
| Shareholders Equity (USD) | 381.26M | ||
| Assets Non-Current | 130.99M | ||
| Liabilities Non-Current | 2.67M | ||
| Trade and Non-Trade Payables | 3.87M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 264.00K | ||
| Net Cash Flow from Financing | 828.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -18.91M | ||
| Capital Expenditure | -356.00K | ||
| Issuance (Purchase) of Equity Shares | 828.00K | ||
| Net Cash Flow from Investing | 11.86M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 12.22M | ||
| Net Cash Flow from Operations | -31.60M | ||
| Share Based Compensation | 7.09M | ||